ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Forma Therapeutics Holdings Inc

Forma Therapeutics Holdings Inc (FMTX)

20.01
0.00
(0.00%)
At close: September 18 4:00PM
20.01
0.00
( 0.00% )

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
20.01
Bid
19.98
Ask
19.40
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
20.01
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

FMTX Latest News

Sickle Cell Disease Association of America & Partners Launch New PSA to Boost Awareness and Understanding of the Disease

The “Believe it!” Campaign Will be Featured on TV Networks and Radio Stations Across the U.S., Driving Viewers to SCDBelieveIT.org The Sickle Cell Disease Association of America, Inc. (SCDAA...

Forma Therapeutics Shares Surge on Takeover by Novo Nordisk

By Colin Kellaher Shares of Forma Therapeutics Holdings Inc. took flight Thursday after the clinical-stage biopharmaceutical company agreed to be acquired by Denmark's Novo Nordisk AS for...

Novo Nordisk to Buy Forma Therapeutics for $1.1 Billion

By Colin Kellaher Novo Nordisk AS on Thursday said it agreed to buy clinical-stage biopharmaceutical company Forma Therapeutics Holdings Inc. for about $1.1 billion in a deal that expands the...

Novo Nordisk to acquire Forma Therapeutics and expand presence in sickle cell disease and rare blood disorders

Novo Nordisk and Forma Therapeutics, Holdings Inc. (Nasdaq: FMTX) today announced that they have entered into a definitive agreement under which Novo Nordisk will acquire Forma Therapeutics for...

Forma Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update

Announced analyses from Phase I study of etavopivat in sickle cell disease indicated reduction of reported pain-related adverse events, supporting potential to reduce vaso-occlusive...

Rigel Pharmaceuticals and Forma Therapeutics Announce Licensing Agreement for Olutasidenib, a Novel Mutant IDH1 Inhibitor for the Potential Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Rigel Pharmaceuticals and Forma Therapeutics Announce Licensing Agreement for Olutasidenib, a Novel Mutant IDH1 Inhibitor for the Potential Treatment of Relapsed or Refractory Acute Myeloid...

Forma Therapeutics to Report Second Quarter 2022 Financial Results and Provide Business Update on August 5, 2022

Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on sickle cell disease (SCD), prostate cancer and other rare hematologic diseases and cancers...

Forma Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on sickle cell disease, prostate cancer and other rare hematologic diseases and cancers, today...

Forma Therapeutics Announces Appointment of New Executive Team Members

Agustín Melián, M.D. to be named Executive Vice President, Head of Research and Development and Linea Aspesi to be named Senior Vice President, Chief Human Resources Officer Appointments...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
XCURExicure Inc
$ 5.69
(148.47%)
7.87M
VEROVenus Concept Inc
$ 1.10
(118.91%)
13.16M
ZEOZeo Energy Corporation
$ 1.57
(37.72%)
102.16k
RELIReliance Global Group Inc
$ 3.231
(24.27%)
151.22k
TBIOTelesis Bio Inc
$ 1.60
(17.65%)
753.36k
SMFLSmart for Life Inc
$ 0.4325
(-44.55%)
2.31M
PGNYProgyny Inc
$ 19.007
(-22.23%)
129.3k
RGFReal Good Food Company Inc
$ 0.3701
(-13.93%)
28.2k
OMEXOdyssey Marine Exploration Inc
$ 1.22
(-12.86%)
4.6M
CRMTAmericas Car Mart Inc
$ 43.75
(-12.43%)
6.95k
VEROVenus Concept Inc
$ 1.10
(118.91%)
13.16M
XCURExicure Inc
$ 5.69
(148.47%)
7.87M
EJHE Home Household Service Holdings Ltd
$ 0.112
(5.66%)
6.58M
NVDANVIDIA Corporation
$ 113.57
(0.18%)
5.79M
OMEXOdyssey Marine Exploration Inc
$ 1.22
(-12.86%)
4.57M

Discussion

View Full Feed
P-Rawl P-Rawl 4 minutes ago
Michael Jordan would be a very good role model for Jake.

Michael Jordan played as part of a team, and was an exceptionally good member of the team.
Jake pretends he's leading a team but is actually trying to play all the positions himself.

Michael Jordan never th
BCAP
goodfree goodfree 5 minutes ago
Ah ok can’t help you there lol
NBRI
threewheeler threewheeler 6 minutes ago
$AHRO $$ The valuation analysis will be based on replacement value, future CF of the asset, and comparative market values of similar libraries.
We are monetizing the asset by virtue of our broadcasting it on Maybacks and receiving ad dollars for it. The value by either or all methods will be
AHRO
rodeoup rodeoup 6 minutes ago
Thanks, I’m using an I pad
NBRI
dinogreeves dinogreeves 6 minutes ago
Lot of bickering on this board for no reason at all. Just know one fact, no one is better than the other. Some win, some lose, some invest, some trade and some dream, in reality everything else is someone's story, in the end it is your pocket book and everyone has a different strategy that works b
BNCM
Staypositive1 Staypositive1 6 minutes ago
AGCO...Fendt
DE
Investor082 Investor082 7 minutes ago
Your BS is exposed, Flip. You make no business sense. Just like NWBO management, you prefer dealing in ambiguity.

How about we make something concrete?

No combo trial deal with a big pharma by end of March? This combo trial deal must involve significant cash payout to
NWBO
Filterthenoise Filterthenoise 7 minutes ago
We own FOXO $RNVA
FOXO RNVA
Dragonman1 Dragonman1 7 minutes ago
They Do have a Choice not to RS, Reverse splits have and never will do anything good for and it Screws shareholders, the fact is this Co needs to keep expanding their operations then by making more money the stock will rise, then the cellar boxing will end due to a massive volume Up swing, Volume sp
BBRW
i_like_bb_stock i_like_bb_stock 7 minutes ago
I haven’t looked honestly
GVDI
gdog gdog 8 minutes ago
9-18 a/h B CLF $11.5975 on news
CLF
beer$$money beer$$money 8 minutes ago
$ASII Buy/Sell Ratio Buy: 49,287,749 Sell: 49,096,270 Neutral: 9,790,724 Volume 108,174,743
ASII
LuckyLovie LuckyLovie 8 minutes ago
Bad time to poop the bed Ray,with Tax Selling Season 60 days away...no buzz word/phrases can stop the plummet of share price to enter the abys...0.0002 now your changing protocols with ai drug co.regular biz. Next thing il be making exotic hotdogs that make nitrous Oxide with Ai...

I
IDVV
moviesam moviesam 8 minutes ago
Do you think Wildfire will be released this year? If it never gets released, do you think the CEO should consider a new business model?
Wildfire started production in August of 2019 so Covid really should not have been used as an excuse for it taking this long to complete.

No
HHSE
BeachBum BeachBum 8 minutes ago
They approved one so they don’t need one? I don’t get it.
KEGS
Dcab Dcab 9 minutes ago
Here is the website from the otc profile.

http://www.goldenvalleydevinc.com/

Has this link updated recently?
GVDI
manibiotech manibiotech 10 minutes ago
Yes
And at ASM they said they haven’t even started the process of writing the pricing model to submit for appraisal as far as I remember and no timeline was given ( unless you consider several months as a timeline )
ASM
Disquisition Disquisition 11 minutes ago
UNIMAGINABLE DELISTING DUMPING!!!!
SMFL
stockanalyze stockanalyze 11 minutes ago
lot of crazy stuff in this election. 0.5% reduction saying inflation is under control.excuse me? fries is still over $4.50 . a subway sandwich that used to be $4.00 is close to $9.00. yeah, do it as you need that fed chair position again.
FNMA
gitreal gitreal 11 minutes ago
I will accept that you are telling the truth about having the auditor confirm that they are handling BMXI's audit. But I stand by my statement that no audit will be done. The auditor may have been asked to respond that way....but normally an auditor will not answer any questions, even just to conf
BMXI
threewheeler threewheeler 12 minutes ago
$AHRO $$ The valuation analysis will be based on replacement value, future CF of the asset, and comparative market values of similar libraries.
We are monetizing the asset by virtue of our broadcasting it on Maybacks and receiving ad dollars for it. The value by either or all methods will be
AHRO

Your Recent History

Delayed Upgrade Clock